To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ODF2LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
255 supporting clones for gene ODF2L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DW425491 Liver ODF2L.a 1 to 268 18 to 285   tiling clone,   268/285
(94 %)
6 diff
(97.9 %id)
DW447076 Liver ODF2L.a 1 to 197 18 to 214       197/214
(92 %)
6 diff
(97.2 %id)
CR591511 placenta ODF2L.a 77 to 2783 1 to 2707 exact tiling clone,   2707/2707
(100 %)
0 diff
(100 %id)
BX430909 placenta ODF2L.a 823 to 1648 1 to 827       825/827
(99 %)
11 diff
(98.7 %id)
BQ894001 dorsal root ganglia ODF2L.a 1050 to 1816 29 to 801       773/979
(78 %)
14 diff
(98.6 %id)
BX453470 placenta ODF2L.a 1054 to 1984 926 to 1       926/971
(95 %)
19 diff
(98.1 %id)
CB148065 Liver ODF2L.a 1160 to 1658 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CB215905 normal endometrium, late proliferativephase, cycle day 13, uterus ODF2L.a 1177 to 1782 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
TI_149308237   ODF2L.a 1209 to 2084 969 to 106   AAA   864/945
(91 %)
25 diff
(97.4 %id)
AA384681 thyroid gland ODF2L.a 1246 to 1492 1 to 251       251/272
(92 %)
5 diff
(98.2 %id)
TI_149281518   ODF2L.a 1305 to 2084 858 to 82   AAA   777/806
(96 %)
14 diff
(98.3 %id)
TI_149304600   ODF2L.a 1305 to 2084 861 to 88   AAA   774/944
(81 %)
6 diff
(99.4 %id)
DA682284 ovary ODF2L.a 1331 to 1901 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
TI_227715566   ODF2L.a 1331 to 2084 841 to 94   AAA   748/963
(77 %)
9 diff
(99.1 %id)
BM971230 lung, Primary Lung Epithelial Cells ODF2L.a 1388 to 2084 715 to 19   AAA   697/697
(100 %)
0 diff
(100 %id)
BM772286 myeloma ODF2L.a 1389 to 2040 1 to 653       653/653
(100 %)
4 diff
(99.4 %id)
BM772288 myeloma ODF2L.a 1389 to 2060 1 to 672       672/672
(100 %)
5 diff
(99.3 %id)
BM983457 lung, Primary Lung Epithelial Cells ODF2L.a 1401 to 2084 702 to 19   AAA   684/684
(100 %)
0 diff
(100 %id)
TI_149307968   ODF2L.a 1408 to 2084 777 to 101   AAA   677/965
(70 %)
0 diff
(100 %id)
BU686861 lung, Primary Lung Epithelial Cells ODF2L.a 1408 to 2084 695 to 19   AAA   677/702
(96 %)
0 diff
(100 %id)
CD366692 Alveolar Macrophage, lung ODF2L.a 1408 to 2084 694 to 19   AAA   676/681
(99 %)
2 diff
(99.8 %id)
BM704095 eye, Retina Foveal and Macular ODF2L.a 1423 to 1791 1 to 369   fully sequenced,   369/369
(100 %)
1 diff
(99.8 %id)
BU687099 lung, Primary Lung Epithelial Cells ODF2L.a 1436 to 2084 667 to 19   AAA   649/649
(100 %)
3 diff
(99.6 %id)
TI_159714389   ODF2L.a 1448 to 1922 537 to 66   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 472/1115
(42 %)
6 diff
(99.5 %id)
CB306905 Human Lung Epithelial cells, lung ODF2L.a 1448 to 1913 468 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 466/469
(99 %)
6 diff
(98.8 %id)
BF435946 pooled ODF2L.a 1524 to 2084 578 to 18   AAA   561/561
(100 %)
1 diff
(99.9 %id)
BU730004 eye, Retina Foveal and Macular ODF2L.a 1761 to 2084 342 to 19   fully sequenced, AAA   324/324
(100 %)
2 diff
(99.4 %id)
NM_001007022.2   ODF2L.b 1 to 4366 4 to 4369 exact RefSeq, AAA   4369/4369
(100 %)
0 diff
(100 %id)
AB033055 brain ODF2L.b 78 to 5732 1 to 5654 Y339H tiling clone, available from KIAA,   5654/5654
(100 %)
14 diff
(99.8 %id)
AA182703   ODF2L.b 1964 to 2421 1 to 462       462/464
(99 %)
9 diff
(98.1 %id)
BM509870 Pancreas, Purified pancreatic islet ODF2L.b 1971 to 2553 596 to 14   AAA   583/583
(100 %)
9 diff
(98.5 %id)
TI_154114100   ODF2L.b 2079 to 2553 557 to 84   tiling clone, AAA   474/475
(99 %)
1 diff
(99.8 %id)
CA448947 Chondrosarcoma, Left Pelvis ODF2L.b 2099 to 2553 472 to 19   AAA   454/454
(100 %)
1 diff
(99.8 %id)
TI_57174517   ODF2L.b 2886 to 3652 61 to 831       771/831
(92 %)
13 diff
(98.5 %id)
BI826657 brain, medulla ODF2L.b 2894 to 3652 1 to 763       763/763
(100 %)
8 diff
(99.0 %id)
BI826858 brain, medulla ODF2L.b 2894 to 3769 1 to 882       882/882
(100 %)
11 diff
(98.8 %id)
TI_57174268   ODF2L.b 2894 to 3769 74 to 955       882/955
(92 %)
6 diff
(99.4 %id)
BU607857 Human Lung Epithelial cells, lung ODF2L.b 3024 to 3599 576 to 1   tiling clone,   576/578
(99 %)
0 diff
(100 %id)
AW811876 stomach ODF2L.b 3094 to 3661 85 to 646       562/647
(86 %)
25 diff
(96.2 %id)
AA179264   ODF2L.b 3113 to 3485 390 to 18   AAA   373/373
(100 %)
1 diff
(99.8 %id)
AW811884 stomach ODF2L.b 3221 to 3908 692 to 9       684/693
(98 %)
0 diff
(100 %id)
AW811904 stomach ODF2L.b 3252 to 3897 648 to 1       648/648
(100 %)
17 diff
(97.4 %id)
CN388958 embryonic stem cells, DMSO-treated H9 cellline ODF2L.b 3391 to 4146 1 to 756       756/756
(100 %)
0 diff
(100 %id)
CX166951 human embryonic stem cells differentiated toan early endodermal cell type ODF2L.b 3470 to 4159 1 to 690       690/690
(100 %)
0 diff
(100 %id)
AA825161 carcinoid, lung ODF2L.b 4036 to 4375 340 to 1       340/340
(100 %)
0 diff
(100 %id)
AA301374 testis ODF2L.b 4323 to 4579 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BF842877 head_neck ODF2L.b 4636 to 4891 5 to 256       252/256
(98 %)
6 diff
(97.7 %id)
CN388956 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ODF2L.b 4818 to 5306 1 to 490   tiling clone,   490/490
(100 %)
1 diff
(99.8 %id)
FN126087 breast carcinoma ODF2L.b 5160 to 5278 1 to 118       118/118
(100 %)
3 diff
(97.5 %id)
FN060151 breast carcinoma ODF2L.b 5162 to 5247 87 to 1     Submitted on the opposite strand 87/87
(100 %)
1 diff
(98.9 %id)
AI807991 pooled ODF2L.b 5501 to 5799 319 to 21   tiling clone, AAA   299/299
(100 %)
7 diff
(97.7 %id)
NM_001184765.1   ODF2L.c 1 to 4154 4 to 4157 exact RefSeq, AAA   4157/4157
(100 %)
0 diff
(100 %id)
BC091490 Pituitary ODF2L.c 99 to 2241 1 to 2143 exact tiling clone, AAA   2143/2143
(100 %)
4 diff
(99.9 %id)
NM_020729.2   ODF2L.d 1 to 4325 4 to 4328 exact RefSeq, AAA   4328/4328
(100 %)
0 diff
(100 %id)
BC047368 Brain, hippocampus ODF2L.d 58 to 4325 1 to 4267 E135G K350R E368* tiling clone, available from MGC, AAA   4267/4267
(100 %)
15 diff
(99.7 %id)
AK302792 testis ODF2L.e 1 to 2489 2 to 2421 E455V S456D L457G Q458N C459H ... tiling clone, Suspected internal deletion 2421/2421
(100 %)
0 diff
(100 %id)
CD686856 normal nasopharynx ODF2L.f 1 to 348 37 to 383       351/383
(91 %)
6 diff
(98.5 %id)
CD687053 normal nasopharynx ODF2L.f 1 to 207 21 to 227   tiling clone,   211/227
(92 %)
9 diff
(96.1 %id)
NM_001184766.1   ODF2L.f 1 to 4067 4 to 4070 exact RefSeq, AAA   4070/4070
(100 %)
0 diff
(100 %id)
AK303209 thymus ODF2L.f 1 to 2154 2 to 2154 exact tiling clone,   2154/2154
(100 %)
5 diff
(99.8 %id)
DB121955 thymus ODF2L.f 1 to 566 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AA129013   ODF2L.f 6 to 460 1 to 454       454/454
(100 %)
11 diff
(97.6 %id)
BF242972 bone marrow, from acute myelogenous leukemia ODF2L.f 15 to 554 1 to 543       543/1347
(40 %)
18 diff
(98.7 %id)
BG428595 Kidney ODF2L.f 16 to 738 1 to 729       729/802
(90 %)
35 diff
(95.7 %id)
DB468635 hippocampus ODF2L.f 17 to 305 1 to 289       289/294
(98 %)
8 diff
(97.3 %id)
BQ438734 testis ODF2L.f 26 to 738 1 to 718       718/840
(85 %)
19 diff
(97.8 %id)
DB083934 testis ODF2L.f 27 to 576 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CX757899 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass ODF2L.f 28 to 735 1 to 708     Submitted on the opposite strand 708/708
(100 %)
0 diff
(100 %id)
DR000406 fetal brain ODF2L.f 35 to 719 1 to 685       685/685
(100 %)
7 diff
(99.0 %id)
BG426287 Kidney ODF2L.f 36 to 594 1 to 554       554/813
(68 %)
12 diff
(98.6 %id)
CN388955 embryonic stem cells, DMSO-treated H9 cellline ODF2L.f 50 to 710 1 to 661       661/661
(100 %)
5 diff
(99.3 %id)
CD703981 normal nasopharynx ODF2L.f 56 to 506 54 to 504       451/504
(89 %)
9 diff
(98.3 %id)
AA312175   ODF2L.f 58 to 478 1 to 425       425/459
(92 %)
7 diff
(98.5 %id)
DB222552 trachea ODF2L.f 58 to 632 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CN388953 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ODF2L.f 66 to 661 1 to 596       596/596
(100 %)
0 diff
(100 %id)
CN388954 embryonic stem cells, DMSO-treated H9 cellline ODF2L.f 71 to 787 9 to 725       717/725
(98 %)
9 diff
(98.8 %id)
CN388957 embryonic stem cells, cell lines H1, H7, andH9 ODF2L.f 91 to 701 1 to 612       612/612
(100 %)
3 diff
(99.6 %id)
DR761418 embryonic stem ODF2L.f 99 to 854 1 to 755       755/755
(100 %)
2 diff
(99.8 %id)
CD105291 brain, Pituitary ODF2L.f 100 to 998 1 to 902       902/910
(99 %)
14 diff
(98.5 %id)
CN398474 embryonic stem cells, DMSO-treated H9 cellline ODF2L.f 128 to 451 1 to 324       324/324
(100 %)
0 diff
(100 %id)
CD694768 normal nasopharynx ODF2L.f 267 to 822 15 to 577       563/577
(97 %)
17 diff
(97.1 %id)
BG610801 adenocarcinoma, Prostate ODF2L.f 279 to 1128 1 to 852   available from MGC,   852/854
(99 %)
23 diff
(97.4 %id)
CD710612 normal nasopharynx ODF2L.f 280 to 454 33 to 207       175/207
(84 %)
6 diff
(97.2 %id)
BC029420 Prostate, adenocarcinoma. ODF2L.f 280 to 1637 1 to 1358   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1358/1368
(99 %)
9 diff
(99.4 %id)
DB210566 trachea ODF2L.f 285 to 837 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA708590   ODF2L.f 287 to 832 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
DA848251 placenta ODF2L.f 287 to 855 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AL542964 placenta ODF2L.f 306 to 1208 1 to 903       903/903
(100 %)
1 diff
(99.9 %id)
BE566037 bladder, carcinoma, cell line ODF2L.f 308 to 822 1 to 519       519/708
(73 %)
12 diff
(98.4 %id)
BF027827 bladder, carcinoma, cell line ODF2L.f 309 to 480 2 to 180       179/191
(93 %)
6 diff
(96.9 %id)
AI886345 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ODF2L.f 365 to 663 299 to 1       299/299
(100 %)
0 diff
(100 %id)
CF145486 CNCAP(3)T-225 cell line, Prostate ODF2L.f 592 to 1304 1 to 713   tiling clone,   713/713
(100 %)
9 diff
(98.8 %id)
CF123026 CNCAP(3)T-225 cell line, Prostate ODF2L.f 592 to 908 1 to 317       317/317
(100 %)
17 diff
(94.7 %id)
TI_154177718   ODF2L.f 599 to 1423 76 to 906       831/871
(95 %)
17 diff
(98.1 %id)
BE877447 large cell carcinoma, undifferentiated, lung ODF2L.f 672 to 1488 1 to 815       815/866
(94 %)
22 diff
(97.5 %id)
BX499763 Liver ODF2L.f 784 to 1348 1 to 565   tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
EC449197 Prostate ODF2L.f 902 to 1014 1 to 113       113/113
(100 %)
0 diff
(100 %id)
TI_149282875   ODF2L.f 908 to 1540 738 to 106       633/884
(71 %)
14 diff
(98.5 %id)
AF114055 brain ODF2L.f 936 to 1140 1 to 205       205/207
(99 %)
3 diff
(98.6 %id)
BU679943 lung, Primary Lung Epithelial Cells ODF2L.f 1009 to 1540 577 to 46   AAA   532/559
(95 %)
3 diff
(99.5 %id)
AI282691 colon, moderately-differentiated adenocarcinoma ODF2L.f 1195 to 1622 425 to 1       425/425
(100 %)
5 diff
(98.9 %id)
CB135425 Liver ODF2L.f 1421 to 1868 18 to 465       448/465
(96 %)
0 diff
(100 %id)
AI074270 colon, colon tumor ODF2L.f 1575 to 1964 432 to 43       390/432
(90 %)
1 diff
(99.8 %id)
BF363848 nervous_normal ODF2L.f 1637 to 1818 18 to 203       187/203
(92 %)
10 diff
(95.1 %id)
AI338465   ODF2L.f 1655 to 2155 504 to 3       502/504
(99 %)
13 diff
(97.5 %id)
TI_159722079   ODF2L.f 1656 to 1942 360 to 74   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 287/393
(73 %)
2 diff
(99.5 %id)
CA944445 Human Lung Epithelial cells, lung ODF2L.f 1656 to 1942 294 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 287/297
(96 %)
2 diff
(99.4 %id)
BQ028844 Bone, Subchondral Bone ODF2L.f 1677 to 2154 496 to 19   AAA   478/478
(100 %)
3 diff
(99.4 %id)
AW474335 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ODF2L.f 1680 to 2155 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AI312591 lung ODF2L.f 1695 to 2154 458 to 1       458/458
(100 %)
5 diff
(99.0 %id)
BE674715 B-cell, chronic lymphotic leukemia ODF2L.f 1723 to 2163 451 to 11   tiling clone, AAA   441/441
(100 %)
0 diff
(100 %id)
AI275893 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 1725 to 2154 430 to 1       430/432
(99 %)
3 diff
(99.4 %id)
AI741045 pooled ODF2L.f 1725 to 2230 518 to 12   AAA   507/509
(99 %)
7 diff
(98.7 %id)
AW081314 colon, moderately differentiated adenocarcinoma ODF2L.f 1727 to 2155 430 to 2       429/430
(99 %)
3 diff
(99.4 %id)
AI890203 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ODF2L.f 1735 to 2154 436 to 17   AAA   420/420
(100 %)
7 diff
(98.4 %id)
AI192785 lung ODF2L.f 1745 to 2155 415 to 5       411/415
(99 %)
2 diff
(99.6 %id)
AI376547 pooled ODF2L.f 1745 to 2154 421 to 12   AAA   410/410
(100 %)
2 diff
(99.6 %id)
AI382078 pooled ODF2L.f 1745 to 2163 419 to 1       419/419
(100 %)
0 diff
(100 %id)
R19548 whole brain ODF2L.f 1747 to 2072 327 to 1     Submitted on the opposite strand 327/327
(100 %)
3 diff
(99.1 %id)
AI769235 pooled ODF2L.f 1751 to 2155 412 to 8       405/412
(98 %)
0 diff
(100 %id)
EL955343 eyeball ODF2L.f 1752 to 2154 460 to 58   AAA Submitted on the opposite strand 403/403
(100 %)
3 diff
(99.3 %id)
AA927822 pooled ODF2L.f 1757 to 2163 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
BQ028973 Bone, Subchondral Bone ODF2L.f 1796 to 2154 377 to 19   AAA   359/359
(100 %)
0 diff
(100 %id)
AI807959 pooled ODF2L.f 1806 to 2155 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AI370112 lung ODF2L.f 1808 to 2155 351 to 3       349/351
(99 %)
3 diff
(99.2 %id)
AA725073 parathyroid gland, parathyroid tumor ODF2L.f 1821 to 2153 343 to 11       333/343
(97 %)
5 diff
(98.6 %id)
AI051770   ODF2L.f 1827 to 2165 344 to 6       339/344
(98 %)
2 diff
(99.5 %id)
AA598799   ODF2L.f 1875 to 2154 291 to 12   AAA   280/280
(100 %)
1 diff
(99.7 %id)
AL569712 placenta ODF2L.f 1913 to 2853 942 to 1   tiling clone,   942/942
(100 %)
15 diff
(98.5 %id)
AA129014   ODF2L.f 1915 to 2160 248 to 1       248/248
(100 %)
3 diff
(98.8 %id)
AI023985 parathyroid gland, parathyroid tumor ODF2L.f 1918 to 2155 245 to 8       238/245
(97 %)
0 diff
(100 %id)
EC522656 Prostate ODF2L.f 1961 to 2074 1 to 112       112/112
(100 %)
5 diff
(95.6 %id)
AA994730 pooled ODF2L.f 1973 to 2147 175 to 1       175/175
(100 %)
3 diff
(98.3 %id)
BG570393 lung ODF2L.f 2062 to 2765 1 to 707       707/707
(100 %)
22 diff
(96.9 %id)
BE840698 prostate_normal ODF2L.f 2071 to 2490 438 to 18       421/446
(94 %)
0 diff
(100 %id)
AW075524 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney ODF2L.f 2072 to 2326 268 to 15   AAA   254/254
(100 %)
1 diff
(99.7 %id)
FN159407 breast carcinoma ODF2L.f 2091 to 2153 1 to 63       63/63
(100 %)
1 diff
(98.5 %id)
BE840638 prostate_normal ODF2L.f 2101 to 2486 8 to 390   tiling clone,   383/400
(95 %)
4 diff
(99.0 %id)
FN047864 breast carcinoma ODF2L.f 2174 to 2297 124 to 1     Submitted on the opposite strand 124/124
(100 %)
0 diff
(100 %id)
CN357674 embryonic stem cells, DMSO-treated H9 cellline ODF2L.f 2275 to 2781 1 to 507   tiling clone, AAA   507/507
(100 %)
0 diff
(100 %id)
BP397002 pancreatic islet ODF2L.f 2328 to 2774 1 to 447     Submitted on the opposite strand 447/448
(99 %)
1 diff
(99.8 %id)
AA857359 pharynx, squamous cell carcinoma ODF2L.f 2490 to 2786 298 to 2       297/298
(99 %)
0 diff
(100 %id)
AI682783 adenocarcinoma, Pancreas ODF2L.f 2494 to 2784 314 to 24   AAA   291/291
(100 %)
4 diff
(98.7 %id)
AI590114 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus ODF2L.f 2551 to 2784 255 to 22   AAA   234/234
(100 %)
1 diff
(99.6 %id)
BX092347 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3343 to 3672 1 to 329   tiling clone,   329/473
(69 %)
2 diff
(99.6 %id)
CR748232 pooled ODF2L.f 3343 to 3672 1 to 330       330/491
(67 %)
5 diff
(99.0 %id)
AA193342 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3372 to 3832 1 to 464       464/541
(85 %)
11 diff
(98.0 %id)
CN312986 embryonic stem cells, cell lines H1, H7, andH9 ODF2L.f 3412 to 4008 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
BM993592 lung, Metastatic Chondrosarcoma ODF2L.f 3496 to 4066 589 to 19   tiling clone, AAA   571/571
(100 %)
4 diff
(99.3 %id)
AW304248 brain, three pooled meningiomas ODF2L.f 3581 to 4055 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AI240260 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3614 to 4047 434 to 1       434/450
(96 %)
3 diff
(99.4 %id)
AI383342 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3657 to 4047 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
AI274037 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3658 to 4049 395 to 4       392/395
(99 %)
0 diff
(100 %id)
F02959 brain, total brain ODF2L.f 3707 to 4047 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AW149943 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ODF2L.f 3822 to 4050 250 to 22   AAA   229/229
(100 %)
4 diff
(98.3 %id)
AA193442 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ODF2L.f 3846 to 4053 208 to 1       208/208
(100 %)
0 diff
(100 %id)
AI470440 pooled ODF2L.f 3853 to 4053 220 to 20   AAA   201/201
(100 %)
0 diff
(100 %id)
BU678640 lung, Primary Lung Epithelial Cells ODF2L.f 3873 to 4053 199 to 19   AAA   181/189
(95 %)
0 diff
(100 %id)
BU608864 Human Lung Epithelial cells, lung ODF2L.f 3873 to 4053 199 to 19   AAA   181/189
(95 %)
0 diff
(100 %id)
BG777878 adenocarcinoma, Prostate ODF2L.g 1 to 687 9 to 695   tiling clone,   695/695
(100 %)
2 diff
(99.8 %id)
BI768058 pooled lung and spleen ODF2L.g 16 to 837 1 to 820   tiling clone,   820/885
(92 %)
11 diff
(98.8 %id)
TI_57180425   ODF2L.g 16 to 837 34 to 853       820/918
(89 %)
16 diff
(98.3 %id)
BC012579 Skin, melanotic melanoma, high MDR. ODF2L.g 24 to 1469 1 to 1443   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1443/1451
(99 %)
12 diff
(99.2 %id)
BF664665 brain, primitive neuroectoderm ODF2L.g 25 to 642 1 to 623       621/738
(84 %)
38 diff
(94.9 %id)
BF691311 melanotic melanoma, high MDR, skin ODF2L.g 27 to 678 1 to 648   available from MGC,   648/867
(74 %)
19 diff
(97.9 %id)
BX472368   ODF2L.g 31 to 678 1 to 646       646/646
(100 %)
4 diff
(99.4 %id)
AW958662   ODF2L.g 33 to 604 1 to 570       570/570
(100 %)
13 diff
(97.8 %id)
ES313582 beard hair, skin ODF2L.g 92 to 515 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
AV746618 Pituitary ODF2L.g 102 to 633 1 to 531       531/547
(97 %)
5 diff
(99.1 %id)
BF207588 bladder, carcinoma, cell line ODF2L.g 256 to 937 1 to 674       674/871
(77 %)
16 diff
(98.2 %id)
BF207775 bladder, carcinoma, cell line ODF2L.g 256 to 842 1 to 586       586/902
(64 %)
10 diff
(98.9 %id)
BE566975 bladder, carcinoma, cell line ODF2L.g 283 to 847 2 to 570       575/780
(73 %)
29 diff
(96.3 %id)
BE568251 bladder, carcinoma, cell line ODF2L.g 283 to 921 2 to 640       645/702
(91 %)
27 diff
(96.2 %id)
BE568883 bladder, carcinoma, cell line ODF2L.g 283 to 903 2 to 620       626/893
(70 %)
49 diff
(94.6 %id)
BE865511 bladder, carcinoma, cell line ODF2L.g 283 to 908 2 to 632       637/637
(100 %)
32 diff
(95.0 %id)
BE866726 bladder, carcinoma, cell line ODF2L.g 283 to 886 2 to 610       615/610
(100 %)
22 diff
(96.4 %id)
DA061971 cerebellum ODF2L.g 1411 to 1972 2 to 563   tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
BM503719 Pancreas, Purified pancreatic islet ODF2L.g 1450 to 2058 1 to 609   tiling clone,   609/609
(100 %)
4 diff
(99.4 %id)
BF208576 bladder, carcinoma, cell line ODF2L.h 1 to 680 3 to 659   tiling clone, available from MGC,   659/839
(78 %)
44 diff
(94.8 %id)
BC009779 Bladder, carcinoma ODF2L.h 1 to 1023 6 to 1026   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1022/1029
(99 %)
7 diff
(99.4 %id)
EL733417 mixed ODF2L.h 272 to 500 1 to 230       230/412
(55 %)
2 diff
(99.6 %id)
AW172516 pooled ODF2L.h 799 to 1199 401 to 1   tiling clone,   401/401
(100 %)
0 diff
(100 %id)
AK308351 thymus ODF2L.i 1 to 1011 2 to 1013   tiling clone,   1013/1013
(100 %)
2 diff
(99.9 %id)
DB144459 thymus ODF2L.i 1 to 543 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BX955119   ODF2L.i 909 to 1606 1 to 698   tiling clone,   698/698
(100 %)
0 diff
(100 %id)
DA876234 Prostate ODF2L.j 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
BI834540 pooled pancreas and spleen ODF2L.j 13 to 810 1 to 796   tiling clone,   796/806
(98 %)
11 diff
(98.7 %id)
TI_57167719   ODF2L.j 13 to 810 55 to 850       796/860
(92 %)
17 diff
(98.1 %id)
AW966584   ODF2L.j 673 to 1218 1 to 546   tiling clone,   546/546
(100 %)
6 diff
(99.0 %id)
BF686018 leiomyosarcoma cell line, uterus ODF2L.k 1 to 783 1 to 778 A21P F22S L23F P24L S25V ... tiling clone,   778/808
(96 %)
27 diff
(96.7 %id)
BG503496 embryonal carcinoma, testis ODF2L.l 1 to 685 1 to 690 I182N E183R T185N E186R L187I ... tiling clone,   690/690
(100 %)
6 diff
(99.2 %id)
CA772345 Pancreas, Purified pancreatic islet ODF2L.m 1 to 579 8 to 586   tiling clone, fully sequenced,   579/586
(98 %)
6 diff
(99.0 %id)
CA772055 Pancreas, Purified pancreatic islet ODF2L.m 518 to 1118 601 to 1   tiling clone, fully sequenced,   601/601
(100 %)
3 diff
(99.6 %id)
DR002460 fetal brain ODF2L.n 1 to 695 17 to 711   tiling clone,   695/711
(97 %)
7 diff
(99.1 %id)
AW793453 uterus ODF2L.n 613 to 1146 569 to 37   tiling clone,   533/569
(93 %)
2 diff
(99.7 %id)
BF106257 lung ODF2L.o 1 to 647 1 to 645 L65C L66F L67C P68H L69Y ... tiling clone,   645/645
(100 %)
8 diff
(98.8 %id)
CA336727 posterior rhombomeres 5-8 (4 pooled) ODF2L.p 1 to 567 567 to 1   tiling clone, Submitted on the opposite strand 567/567
(100 %)
1 diff
(99.9 %id)
AV754062 pituitary tumor ODF2L.p 89 to 530 1 to 444   tiling clone,   444/490
(90 %)
8 diff
(98.4 %id)
BG425757 Kidney ODF2L.p 525 to 1101 1 to 587   tiling clone,   587/1090
(53 %)
29 diff
(97.4 %id)
R87080 liver and spleen ODF2L.p 693 to 1062 1 to 386       386/434
(88 %)
20 diff
(95.4 %id)
N90466 liver and spleen ODF2L.p 693 to 1014 1 to 322   tiling clone,   322/322
(100 %)
1 diff
(99.7 %id)
AA921853 pooled ODF2L.p 910 to 1434 525 to 1   tiling clone,   525/525
(100 %)
1 diff
(99.9 %id)
AW292767   ODF2L.p 976 to 1472 530 to 33   AAA   498/513
(97 %)
0 diff
(100 %id)
AW292768   ODF2L.p 977 to 1463 527 to 42   AAA   486/510
(95 %)
0 diff
(100 %id)
BE082504 breast ODF2L.p 1023 to 1444 1 to 422   tiling clone,   422/422
(100 %)
5 diff
(98.9 %id)
AW969204   ODF2L.p 1029 to 1604 579 to 4     Submitted on the opposite strand 576/580
(99 %)
0 diff
(100 %id)
CN288830 embryonic stem cells, DMSO-treated H9 cellline ODF2L.p 1113 to 1414 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
N69203 liver and spleen ODF2L.p 1153 to 1476 327 to 3       325/327
(99 %)
0 diff
(100 %id)
R86953 liver and spleen ODF2L.p 1159 to 1438 285 to 1       285/285
(100 %)
5 diff
(98.3 %id)
AA521186 germinal center B cell ODF2L.p 1337 to 1609 273 to 1   tiling clone,   273/273
(100 %)
0 diff
(100 %id)
AW793446 uterus ODF2L.p 1380 to 2464 2 to 496       504/497
(101 %)
39 diff
(92.2 %id)
BX107142 whole brain ODF2L.p 1519 to 1987 1 to 472   tiling clone,   472/472
(100 %)
8 diff
(98.4 %id)
BG567805 Liver ODF2L.q 1 to 819 1 to 817 N35I N37M V38* tiling clone,   818/827
(98 %)
26 diff
(96.9 %id)
CB962320 Blood vessels - aorta, basilar and artery ODF2L.r 1 to 548 1 to 547 T127L S128L Y129M V130* tiling clone,   547/578
(94 %)
5 diff
(99.2 %id)
AL703770 human skeletal muscle ODF2L.s 1 to 600 1 to 600 exact tiling clone,   600/600
(100 %)
3 diff
(99.5 %id)
BG699883 brain, hippocampus ODF2L.s 3 to 713 6 to 717 P17T S51A available from MGC,   712/717
(99 %)
9 diff
(98.8 %id)
BX510114   ODF2L.s 18 to 750 1 to 733 exact tiling clone,   733/733
(100 %)
1 diff
(99.9 %id)
CD705327 normal nasopharynx ODF2L.s 26 to 560 24 to 557 exact     534/557
(95 %)
9 diff
(98.4 %id)
CD685669 normal nasopharynx ODF2L.s 43 to 477 23 to 457 F54C     435/457
(95 %)
9 diff
(98.1 %id)
BI550925 brain, hippocampus ODF2L.s 43 to 799 1 to 762 exact     762/766
(99 %)
19 diff
(97.6 %id)
DB161687 thymus ODF2L.s 44 to 633 2 to 591 exact capped   590/590
(100 %)
0 diff
(100 %id)
TI_44171996   ODF2L.s 49 to 799 87 to 842 exact     756/846
(89 %)
21 diff
(97.6 %id)
CN398475 embryonic stem cells, DMSO-treated H9 cellline ODF2L.s 52 to 623 1 to 572 exact     572/572
(100 %)
0 diff
(100 %id)
CR741741 parathyroid gland, parathyroid tumor ODF2L.s 56 to 530 1 to 477 T66D T67D C68V G69R R70T ...     477/479
(99 %)
5 diff
(99.0 %id)
AI817989 normal prostate, Prostate ODF2L.s 69 to 571 504 to 2 exact     503/504
(99 %)
0 diff
(100 %id)
AW452022   ODF2L.s 75 to 570 513 to 18   AAA   496/496
(100 %)
0 diff
(100 %id)
AW274155 pooled ODF2L.s 148 to 552 409 to 5       405/409
(99 %)
0 diff
(100 %id)
BE858303 Prostate ODF2L.s 148 to 571 425 to 2       424/425
(99 %)
1 diff
(99.8 %id)
AW449997   ODF2L.s 212 to 570 377 to 19   AAA   359/359
(100 %)
3 diff
(99.2 %id)
AW614277 Kidney ODF2L.s 229 to 550 324 to 1       324/324
(100 %)
7 diff
(97.9 %id)
CK023995 brain/CNS, Human Brain - Frontal Cortex ODF2L.s 257 to 954 1 to 686       686/708
(96 %)
40 diff
(94.4 %id)
AI948502 2 pooled tumors (clear cell type), Kidney ODF2L.s 266 to 571 308 to 3       306/308
(99 %)
0 diff
(100 %id)
AI377396   ODF2L.s 426 to 990 560 to 1       560/560
(100 %)
8 diff
(98.6 %id)
AA452843   ODF2L.s 569 to 990 417 to 1   tiling clone,   417/417
(100 %)
8 diff
(98.1 %id)
AW591693 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors ODF2L.s 669 to 1001 336 to 1   tiling clone,   336/336
(100 %)
4 diff
(98.9 %id)
AW368345 head_neck ODF2L.t 1 to 425 1 to 426   tiling clone,   426/426
(100 %)
7 diff
(98.4 %id)
AA318228 retina ODF2L.t 294 to 685 1 to 392 E34X E70X tiling clone,   392/392
(100 %)
1 diff
(99.8 %id)
CA950514 Pancreas, Purified pancreatic islet ODF2L.u 1 to 631 1 to 631 A12T Q29P tiling clone,   631/631
(100 %)
5 diff
(99.3 %id)
AI701928 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus ODF2L.u 108 to 583 475 to 1   tiling clone,   475/475
(100 %)
1 diff
(99.8 %id)
CA949998 Pancreas, Purified pancreatic islet ODF2L.va-u 1 to 523 1 to 523   tiling clone,   523/523
(100 %)
0 diff
(100 %id)
AA384498 thyroid gland ODF2L.va-u 443 to 764 1 to 323   tiling clone,   323/323
(100 %)
5 diff
(98.5 %id)
CB984471 Pooled-Glandular ODF2L.va-u 463 to 1143 1 to 693   tiling clone,   693/784
(88 %)
43 diff
(94.6 %id)
BE891102 melanotic melanoma, skin ODF2L.va-u 919 to 1645 1 to 717   tiling clone,   717/914
(78 %)
8 diff
(99.2 %id)
CV426531 breast_normal ODF2L.va-u 1344 to 1754 5 to 415 S19R F29X tiling clone,   411/415
(99 %)
6 diff
(98.6 %id)
BM149799 leukopheresis ODF2L.vb 1 to 332 1 to 334       334/336
(99 %)
25 diff
(92.6 %id)
BM150300 leukopheresis ODF2L.vb 1 to 656 1 to 656   tiling clone,   656/657
(99 %)
1 diff
(99.9 %id)
DA122732 cerebellum ODF2L.vb 233 to 772 2 to 541 exact tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
BI491826 cochlea, ear ODF2L.vc-u 1 to 558 561 to 4 exact tiling clone,   558/568
(98 %)
0 diff
(100 %id)
AA772124 parathyroid gland, parathyroid tumor ODF2L.vc-u 39 to 571 536 to 4 exact tiling clone,   533/536
(99 %)
0 diff
(100 %id)
BF333659 colon_normal ODF2L.vc-u 110 to 364 7 to 262 L19S V20G E21*     256/278
(92 %)
15 diff
(94.7 %id)
DB536000 hippocampus ODF2L.vc-u 118 to 568 1 to 451 E21N F22L V23L M24*   Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
DB549621 hippocampus ODF2L.vc-u 126 to 568 1 to 443 exact   Submitted on the opposite strand 443/443
(100 %)
0 diff
(100 %id)
GD161226   ODF2L.vc-u 245 to 396 1 to 152       152/153
(99 %)
4 diff
(97.4 %id)
AI376178   ODF2L.vd-u 1 to 499 499 to 1 exact tiling clone,   499/499
(100 %)
0 diff
(100 %id)
BM174934 hippocampus ODF2L.ve-u 1 to 438 457 to 19 A4T E13K F15C I21R E25K ... tiling clone,   439/457
(96 %)
0 diff
(100 %id)
BF372038 prostate_tumor ODF2L.vf-u 1 to 388 1 to 389 G18S F48C Y55L tiling clone,   389/389
(100 %)
7 diff
(98.3 %id)
BF372113 prostate_tumor ODF2L.vf-u 56 to 430 382 to 9   tiling clone,   374/382
(97 %)
0 diff
(100 %id)
CN290684 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ODF2L.vg-u 1 to 424 1 to 424 exact tiling clone,   424/424
(100 %)
0 diff
(100 %id)
AI522267 Kidney ODF2L.vh 1 to 311 318 to 8 exact tiling clone,   311/318
(97 %)
0 diff
(100 %id)
AI473444 poorly differentiated adenocarcinoma withsignet ring cell features, stomach ODF2L.vi-u 1 to 159 169 to 11 exact tiling clone, AAA   159/159
(100 %)
0 diff
(100 %id)
BM750806 Ascites, stomach Gene ODF2L, variant not shown         Suspected internal deletion, this clone was ignored    
BC026105 Brain, hippocampus Gene ODF2L, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc-u, .vd-u, .ve-u, .vf-u, .vg-u, .vh, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI